Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

PharmaZen doubles capacity to keep up with demand

PharmaZen doubles capacity to keep up with demand


Freeze dryer ­
PharmaZen chief executive Craig McIntosh inspects product
coming from the new freeze dryer.
Click to enlarge

Freeze dryer ­ PharmaZen chief executive Craig McIntosh inspects product coming from the new freeze dryer.

Freeze dryer ­
PharmaZen chief executive Craig McIntosh inspects product
coming from the new freeze dryer.
Click to enlarge

Freeze dryer ­ PharmaZen chief executive Craig McIntosh inspects product coming from the new freeze dryer.

For Immediate Release

Thursday, November 2

PharmaZen doubles capacity to keep up with demand


Biotechnology company PharmaZen has just invested $1m in plant and machinery which will double the company's potential turnover from $7 million to $14 million per year.

With demand outstripping supply for the company's animal and human health products, the cost of the new plant will be recovered very quickly.

Shares in PharmaZen are traded through the unregistered securities trading facility.

PharmaZen chief executive, Craig McIntosh, said the investment has predominantly been in milling and drying while other efficiencies had also been gained on the operational side with a significant investment in a heat recovery system.

The Company's most notable investment has been in a purpose designed vacuum drying system which can also be operated as a wet processing unit.

"We had looked around for an off the shelf solution which would enable us to wet process product and then continue through into a drying stage without the need to transfer product to another vessel (traditional technology). When we couldn't find a suitable solution we looked at the feasibility of having one designed and built, which is what we did."

The unit was finally commissioned in October and the company is extremely happy with the results, reporting not only the anticipated increase in throughput but an improvement in product yield due to reduced handling losses.

"There were a lot of teething problems which were always to be expected on such an innovative project and overall it took a lot longer than anticipated to have it up and running but in terms of performance it is better than we could have hoped for."

The plant upgrade is scheduled for completion early next month.

The new plant has been installed in PharmaZen's wholly-owned Waitaki Biosciences International unit in Christchurch where it manufactures a range of powder products extracted from a wide range of animal and marine sources. The range includes green-lipped mussel, shark cartilage, natural calcium and Chondroitin Sulphate. The products are used by other companies as a base for health products, mainly in the areas of bone health, joint health, immune and digestive support.


"We have always struggled to keep up with demand. Our level of efficiency was poor but that has increased markedly over the last 12 months and now we have the capacity to go to a new level," he said.

The company reported a loss of $183,000 on turnover of $5.58million for the 2005 year. It anticipates turnover of $6 million for 2006 with a significant lift in profit.


ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 


Commerce Commission: Appeals Record $2.25m Fine In Vodafone FibreX Case

The Commerce Commission has filed an appeal in the High Court against a record $2.25 million fine imposed on Vodafone NZ Limited (Vodafone) for its offending under the Fair Trading Act during its FibreX advertising campaign. While the sentence imposed in the Auckland District Court on April 14 was the largest-ever fine under the Fair Trading Act, the Commission will argue that it is manifestly inadequate... More>>



All District Health Boards: Historic Pay Equity Settlement

An historic agreement has been ratified that addresses a long-standing undervaluation of a workforce that is critical to the smooth running of our hospitals and the delivery of healthcare... More>>


MPI: Dry Autumn In Waikato And South Auckland Leads To Drought Classification Drought conditions affecting the primary sector in the Waikato and South Auckland were today classified as a medium-scale adverse event, enabling a package of support for farmers and growers... More>>


Barfoot & Thompson: Rents Up By Around 3% In Most Areas

The average weekly rent paid for homes in most areas of Auckland has risen by around 3 percent year-on-year. The figures for end March from more than 16,000 properties... More>>


DoC: Smeagol The ‘Gravel Maggot’ Leaves Its Rare Mark On The Remote West Coast
An extremely rare species of sea slug or ‘gravel maggot’ has been detected for the first time on a remote beach in South Westland... More>>



Immigration: Annual Net Migration Loss Of 7,300

The provisional net loss of 7,300 people in the year ended March 2022 was the lowest net migration for a March year since 2012, Stats NZ said today... More>>